SPL 2.22% 9.2¢ starpharma holdings limited

"There has to be more news about the next step of...

  1. 6,451 Posts.
    lightbulb Created with Sketch. 2626
    "There has to be more news about the next step of development."

    Well this is the bit I don't really get. As far as I have researched, Remdesivir is under patent protection. So they would need to be working with Gilead on this product otherwise it would be pointless. So have they left it to the investor to put two and two together or will Gilead make an announcement themselves given it would allow mass distribution of their product or have Starpharma just played in their lab and are hoping to get a phone call from Gilead? The only 3 options my little brain can think of.

    So why not spell out to investors the next steps in their announcement rather than have them guessing?
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.2¢
Change
0.002(2.22%)
Mkt cap ! $37.93M
Open High Low Value Volume
9.2¢ 9.3¢ 9.2¢ $3.349K 36.18K

Buyers (Bids)

No. Vol. Price($)
2 113072 9.2¢
 

Sellers (Offers)

Price($) Vol. No.
9.3¢ 108436 2
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.